The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2023
DOI: 10.1016/j.isci.2022.105798
|View full text |Cite
|
Sign up to set email alerts
|

ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
12
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 22 publications
(48 citation statements)
references
References 301 publications
1
12
0
Order By: Relevance
“…Discrepancies are also seen between the activities of Amuc_0010 GH29 and Amuc_1120 GH95 against HMOs, with the latter releasing more fucose and, therefore, these particular HMOs have predominantly lacto-N-tetraose structures (Supplementary Figure 7). These two observations correspond to the understanding of type II structures being present on red blood cells and type I structures being associated with glycan decorations on secretions 16 . Notably, Amuc_0010 GH29 clusters on a phylogenetic tree with 'Mfuc5' from a soil metagenome and has comparable activities 22 .…”
Section: α-Fucosidasessupporting
confidence: 84%
See 2 more Smart Citations
“…Discrepancies are also seen between the activities of Amuc_0010 GH29 and Amuc_1120 GH95 against HMOs, with the latter releasing more fucose and, therefore, these particular HMOs have predominantly lacto-N-tetraose structures (Supplementary Figure 7). These two observations correspond to the understanding of type II structures being present on red blood cells and type I structures being associated with glycan decorations on secretions 16 . Notably, Amuc_0010 GH29 clusters on a phylogenetic tree with 'Mfuc5' from a soil metagenome and has comparable activities 22 .…”
Section: α-Fucosidasessupporting
confidence: 84%
“…These displayed activity towards blood group B (BGB) Types I and II and Galα1,3-Gal/GalNAc (Figure 1; Supplementary Figures 13-16). BGB is slightly less prevalent than BGA in the human population, ranging between 0-30 %, depending on geographical location 16 . In addition, Amuc_1463 GH110 was also able to hydrolyse the α1,4-linked galactose on globotriose fully and P1 antigen partially under the conditions tested.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…As adaptive immunity is predicted to be limited in this scenario, innate immune factors, which are not subject to the same tolerance programs, may have evolved to protect individuals from microbes that utilize molecular mimicry to evade humoral immunity 13 . Prior examples of innate immunity against molecular mimicry primarily focused on ABO(H) blood group antigens 15 , 26 , 36 , 51 . This was in part due to differences in anti-A and anti-B antibody production based on polymorphic ABO(H) blood group status that had been recognized for over a century 52 .…”
Section: Discussionmentioning
confidence: 99%
“…In contrast to red blood cell (RBC)-induced alloantibody formation ( 13 , 14 , 15 , 16 , 17 , 18 , 19 ), antibodies against ABO(H) antigens are naturally occurring and form within the first few months of life ( 20 ). While conflicting data exist regarding the development of naturally occurring anti-ABO(H) antibodies ( 21 , 22 , 23 , 24 , 25 ), several studies suggest that microbes that express ABO(H)-like antigens may stimulate anti-ABO(H) antibody formation relevant to transfusion and transplantation ( 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 ). However, as tolerance mechanisms prevent the formation of anti-ABO(H) antibodies in ABO(H) blood group–positive individuals, how these individuals protect themselves against blood group–decorated microbes is incompletely understood.…”
mentioning
confidence: 99%